,X,FilingDate,TradeDate,Ticker,InsiderName,Title,TradeType,Price,Qty,Owned,delta_Own,Value,1d,1w,1m,6m,ticker
0,,2022-03-31 10:24:43,2022-03-29,LH,Schroeder Mark S,"EVP, Pres-Diagnostics Lab",S - Sale,277.11,-2356,6605,-26%,-652871.0,,,,,LH
1,,2022-03-31 10:20:43,2022-03-29,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale,277.11,-2449,5287,-32%,-678642.0,,,,,LH
2,,2022-03-29 09:46:41,2022-03-25,LH,Williams R Sanders,Dir,S - Sale,272.98,-572,6431,-8%,-156145.0,,,,,LH
3,,2022-03-14 16:36:55,2022-03-10,LH,Summy Amy B.,"EVP, CMO",S - Sale,262.21,-249,250,-50%,-65290.0,,,,,LH
4,,2022-02-18 20:46:25,2022-02-16,LH,Neupert Peter M,Dir,P - Purchase,263.66,3500,10254,+52%,922815.0,,,,,LH
5,,2022-02-17 15:05:19,2022-02-15,LH,Schroeder Mark S,"EVP, Pres-Diagnostics Lab",S - Sale,273.98,-207,6605,-3%,-56714.0,,,,,LH
6,,2022-02-17 15:03:34,2022-02-15,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale,273.98,-207,5287,-4%,-56714.0,,,,,LH
7,D,2022-02-08 11:08:32,2022-02-07,LH,Schroeder Mark S,"EVP, Pres-Diagnostics Lab",S - Sale+OE,277.38,-204,6605,-3%,-56586.0,,,,,LH
8,D,2022-02-08 11:01:19,2022-02-07,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale+OE,277.38,-218,5287,-4%,-60469.0,,,,,LH
9,D,2022-02-04 12:15:41,2022-02-03,LH,Schroeder Mark S,"EVP, Pres-Diagnostics Lab",S - Sale+OE,271.81,-161,6401,-2%,-43761.0,,,,,LH
10,D,2022-02-04 12:14:42,2022-02-03,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale+OE,271.81,-172,5287,-3%,-46751.0,,,,,LH
11,,2021-12-17 10:36:19,2021-12-15,LH,Gilliland Dwight Gary,Dir,S - Sale,302.26,-500,6252,-7%,-151128.0,,,,,LH
12,D,2021-09-17 12:20:09,2021-09-15,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale+OE,296.78,-4500,5265,-46%,-1335510.0,,,,,LH
13,D,2021-06-09 14:03:55,2021-06-07,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale+OE,266.56,-4500,5237,-46%,-1199520.0,,,,,LH
14,,2021-05-10 08:21:44,2021-05-06,LH,Kirchgraber Paul R,"CEO, Covance Drug Development",S - Sale,276.55,-2500,7844,-24%,-691375.0,,,,,LH
15,D,2021-05-05 10:48:19,2021-05-03,LH,Belingard Jean-Luc,Dir,S - Sale+OE,269.16,-2600,15569,-14%,-699803.0,,,,,LH
16,,2021-04-01 08:32:56,2021-03-30,LH,Schroeder Mark S,"EVP, Pres-Diagnostics Lab",S - Sale,251.88,-667,5006,-12%,-168004.0,,,,,LH
17,,2021-04-01 08:32:01,2021-03-30,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale,251.88,-812,5237,-13%,-204527.0,,,,,LH
18,D,2021-02-19 14:17:58,2021-02-18,LH,Wilkinson Peter J,"SVP, Chief Accounting Officer",S - Sale+OE,241.52,-2317,976,-70%,-559589.0,,,,,LH
19,D,2021-02-17 16:28:36,2021-02-16,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale+OE,236.55,-208,4426,-4%,-49202.0,,,,,LH
20,D,2021-02-17 16:27:07,2021-02-16,LH,Schroeder Mark S,"EVP, Pres-Diagnostics Lab",S - Sale+OE,237.06,-188,4339,-4%,-44567.0,,,,,LH
21,D,2021-02-08 15:43:36,2021-02-05,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale+OE,225.85,-109,4219,-3%,-24618.0,,,,,LH
22,D,2021-02-08 15:40:35,2021-02-05,LH,Schroeder Mark S,"EVP, Pres-Diagnostics Lab",S - Sale+OE,225.85,-203,4152,-5%,-45848.0,,,,,LH
23,,2020-11-10 10:48:49,2020-11-06,LH,Schroeder Mark S,"EVP, Pres-Diagnostics Lab",S - Sale,214.59,-588,3949,-13%,-126179.0,,,,,LH
24,,2020-11-06 09:06:09,2020-11-04,LH,Kirchgraber Paul R,"CEO, Covance Drug Development",S - Sale,214.14,-1500,7698,-16%,-321204.0,,,,,LH
25,D,2020-07-10 16:25:02,2020-07-08,LH,Williams R Sanders,Dir,S - Sale+OE,173.12,-1300,5095,-20%,-225056.0,,,,,LH
26,,2020-07-07 09:38:23,2020-07-02,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale,170.0,-435,4044,-10%,-73950.0,,,,,LH
27,,2020-06-26 10:06:12,2020-06-24,LH,Van Der Vaart Sandra D,"EVP, GC",S - Sale,160.33,-872,4479,-16%,-139808.0,,,,,LH
28,,2020-05-07 12:05:56,2020-05-05,LH,King David P,Dir,S - Sale,160.0,-31250,332096,-9%,-5000000.0,,,,,LH
29,M,2020-05-04 10:18:12,2020-02-28,LH,Seltz Judith C,"EVP, CHRO",P - Purchase,171.31,580,580,New,99360.0,,,,,LH
30,,2020-02-25 12:59:55,2020-02-21,LH,Wilkinson Peter J,"SVP, Chief Accounting Officer",S - Sale,189.65,-297,297,-50%,-56326.0,,,,,LH
31,D,2020-02-21 15:52:46,2020-02-19,LH,Belingard Jean-Luc,Dir,S - Sale+OE,189.76,-26479,14682,-64%,-5024750.0,,,,,LH
32,D,2020-02-14 17:11:37,2020-02-13,LH,Van Der Vaart Sandra D,"SVP, Global GC",S - Sale+OE,188.49,-208,2736,-7%,-39206.0,,,,,LH
33,D,2020-02-14 17:07:51,2020-02-13,LH,Schroeder Mark S,"EVP, Pres-Diagnostics Lab",S - Sale+OE,188.49,-188,486,-28%,-35436.0,,,,,LH
34,D,2020-02-14 15:08:13,2020-02-13,LH,Williams R Sanders,Dir,S - Sale+OE,188.49,-1227,5095,-19%,-231277.0,,,,,LH
35,D,2020-02-11 13:47:45,2020-02-10,LH,Schroeder Mark S,"EVP, Pres-Diagnostics Lab",S - Sale+OE,181.99,-108,300,-26%,-19655.0,,,,,LH
36,D,2020-02-11 13:45:04,2020-02-10,LH,Van Der Vaart Sandra D,"SVP, Global GC",S - Sale+OE,181.99,-133,2529,-5%,-24205.0,,,,,LH
37,,2019-10-30 17:25:03,2019-10-28,LH,King David P,"Pres, CEO",S - Sale,165.4,-30177,325475,-8%,-4991217.0,,,,,LH
38,D,2019-09-25 13:40:11,2019-09-23,LH,Anderson Kerrii B,Dir,S - Sale+OE,171.85,-2600,19133,-12%,-446810.0,,,,,LH
39,D,2019-09-06 09:54:44,2019-09-04,LH,Uthgenannt Lisa J,CHRO,S - Sale+OE,168.59,-2466,4660,-35%,-415743.0,,,,,LH
40,,2019-09-04 09:04:10,2019-08-30,LH,Berberian Lance,"SVP, CIO",S - Sale,169.8,-5902,6097,-49%,-1002172.0,,,,,LH
41,,2019-08-07 11:40:15,2019-08-05,LH,Williams R Sanders,Dir,S - Sale,162.91,-500,6886,-7%,-81455.0,,,,,LH
42,,2019-07-10 09:03:06,2019-07-08,LH,Eisenberg Glenn A,"CFO, EVP",S - Sale,176.75,-5563,17059,-25%,-983260.0,,,,,LH
43,,2019-07-10 09:02:11,2019-07-08,LH,Van Der Vaart Sandra D,"SVP, Global GC",S - Sale,176.75,-2328,2328,-50%,-411474.0,,,,,LH
44,D,2019-06-21 15:26:35,2019-06-20,LH,Anderson Kerrii B,Dir,S - Sale+OE,170.0,-3100,19133,-14%,-527000.0,,,,,LH
45,,2019-06-11 18:16:59,2019-06-07,LH,Eisenberg Glenn A,"CFO, EVP",S - Sale,167.4,-10000,22622,-31%,-1673970.0,,,,,LH
46,,2019-05-08 08:21:50,2019-05-06,LH,Williams R Sanders,Dir,S - Sale,162.2,-500,7386,-6%,-81100.0,,,,,LH
47,D,2019-05-07 11:00:40,2019-05-03,LH,Mittelstaedt Robert E Jr,Dir,S - Sale+OE,166.3,-3700,15209,-20%,-615310.0,,,,,LH
48,,2019-05-06 08:45:09,2019-05-02,LH,Uthgenannt Lisa J,CHRO,S - Sale,164.0,-4000,4638,-46%,-656000.0,,,,,LH
49,D,2019-02-14 17:01:35,2019-02-12,LH,Belingard Jean-Luc,Dir,S - Sale+OE,146.06,-3700,34013,-10%,-540407.0,,,,,LH
50,D,2019-02-14 16:18:54,2019-02-13,LH,Williams R Sanders,Dir,S - Sale+OE,147.0,-1038,7886,-12%,-152586.0,,,,,LH
51,,2018-11-29 10:00:01,2018-11-27,LH,Williams R Sanders,Dir,S - Sale,162.14,-350,7886,-4%,-56749.0,,,,,LH
52,D,2018-11-07 10:54:13,2018-11-05,LH,Anderson Kerrii B,Dir,S - Sale+OE,163.29,-3700,18095,-17%,-604162.0,,,,,LH
53,D,2018-06-08 11:11:07,2018-06-06,LH,Dodson Edward T,Principal Accounting Officer,S - Sale+OE,183.35,-13000,9113,-59%,-2383558.0,,,,,LH
54,,2018-06-06 14:59:16,2018-06-04,LH,Uthgenannt Lisa J,CHRO,S - Sale,182.1,-4500,3755,-55%,-819451.0,,,,,LH
55,,2018-06-04 16:17:22,2018-05-31,LH,Gilliland Dwight Gary,Dir,S - Sale,181.29,-1263,3501,-27%,-228967.0,,,,,LH
56,,2018-06-04 16:16:13,2018-05-31,LH,Berberian Lance,"SVP, CIO",S - Sale,182.3,-5500,5940,-48%,-1002672.0,,,,,LH
57,,2018-06-01 08:15:12,2018-05-30,LH,Gary M. Huff,"CEO, LabCorp Diagnostics",S - Sale,182.5,-1610,1610,-50%,-293823.0,,,,,LH
58,,2018-06-01 08:14:03,2018-05-30,LH,Eisenberg Glenn A,"CFO, EVP",S - Sale,181.21,-10000,15563,-39%,-1812065.0,,,,,LH
59,D,2018-05-25 11:15:05,2018-05-23,LH,King David P,"Pres, CEO",S - Sale+OE,175.37,-49966,296837,-14%,-8762344.0,,,,,LH
